A message from the President

Welcome to Boehringer Ingelheim (Canada) Ltd./Ltée!

As one of the world’s top 20 leading pharmaceutical companies, we indeed play an important role in the health of Canadians. As we approach our 125th anniversary as a family-owned company, we have steadily practiced excellence, innovation and value in the discovery and development of medicines and services.

As a company and as individuals, our corporate culture is built on our guiding principle, Value through Innovation, and is at the heart of all that we do. In living each day by this principle, we are inspired to make significant contributions to areas of unmet therapeutic need for human kind. We invite you to explore examples of this throughout the website.

In our quest for innovation, I am firmly committed to the belief that research and development is the foundation of a bright future for healthcare. As a member of Canada’s Research-Based Pharmaceutical Companies, we maintain this commitment through our ongoing investment in major research activities around the globe. These activities, along with our collaborative efforts and partnerships with external partners, government, and medical professionals, are what will help us provide patients with the best medicines possible.

In the coming years, we look ahead with the confidence that our therapeutic developments will serve to enhance the lives of Canadians, as well as instill a sense of hope and inspiration.

As we look toward the future, we remain committed to being a top employer and building on our greatest asset, our people.

Sincerely,



Dr. Theodore J. Witek Jr.
President & CEO